Demonstrating the feasibility and potential clinical utility of this approach, a previous untargeted autoimmune profiling study comparing young people with first-episode psychosis and healthy controls identified a novel autoantibody target in the N-terminal portion of the p antigen (PAGE) protein group (PAGE2B/PAGE2/PAGE5), which was found in cases only and associated with the later development of SCZ as opposed to other first-episode psychosis outcomes [13]. The gene discussed is PAGE2; the disease is psychotic disorder.